Antígenos HLA-B - CISMeF

CISMeF

chu

Antígenos HLA-BDescripteur MeSH

Preferred Label : Antígenos HLA-B;

Is substance : O;

Details

Origin ID

D015235;

UMLS CUI

C0019737;

Allowable qualifiers
- Administracion y dosis [MeSH Qualifier]
- Analisis [MeSH Qualifier]
- Biosintesis [MeSH Qualifier]
- Efectos Adversos [MeSH Qualifier]
- Liquido cefalorraquideo [MeSH Qualifier]
- Sangre [MeSH Qualifier]
- aislamiento y purificacion [MeSH Qualifier]
- clasificacion [MeSH Qualifier]
- contraindicaciones [MeSH Qualifier]
- economia [MeSH Qualifier]
- efectos de la radiacion [MeSH Qualifier]
- effecto farmacologico [MeSH Qualifier]
- envenenamiento [MeSH Qualifier]
- farmacologia [MeSH Qualifier]
- fisiologia [MeSH Qualifier]
- genetica [MeSH Qualifier]
- historia [MeSH Qualifier]
- inmunologia [MeSH Qualifier]
- metabolismo [MeSH Qualifier]
- orina [MeSH Qualifier]
- quimica [MeSH Qualifier]
- toxicidad [MeSH Qualifier]
- ultraestructura [MeSH Qualifier]
- uso terapeutico [MeSH Qualifier]
Currated CISMeF NLP mapping
- HLA-B [LOINC component]
- antígeno leucocitario humano (HLA) B (sustancia) [Concepto SNOMED CT]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
20/06/2025

© Rouen University Hospital. Any partial or total use of this material must mention the source.